Freestone Grove Partners LP Care Dx, Inc. Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 14,620 shares of CDNA stock, worth $361,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,620Holding current value
$361,114% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
217Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$131 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$120 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$65.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$59.5 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$54.5 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.32B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...